VEGF antagonist (Aciont)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameVEGF antagonist (Aciont)
Drug Alias NameDry/wet age related macular degeneration therapeutic (Aciont)dry/wet age related macular degeneration therapeutic (Aciont)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsWet age-related macular degenerationGeographic Atrophy
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAciont Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAciont Inc
Active IndicationsN/A
Inactive IndicationsWet age-related macular degenerationGeographic Atrophy

Other Information

ATC CodeN/A
Related LinksN/A